Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Clinical trial NCT07128355 · RECRUITING

Trial details

NCT number: NCT07128355
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis

Start date: 2026-05-12
Primary completion: 2027-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.